CCL20 Blockade Mitigates the Progression of AKI to CKD
Kyung Don Yoo(Ulsan College), Seung Hee Yang(Friedrich-Alexander-Universität Erlangen-Nürnberg), Mi‐Yeon Yu(Hanyang University Guri Hospital), Hyung Ah Jo(Inje University Ilsan Paik Hospital), Kyu Hong Kim(Seoul National University), Dong Ki Kim(Seoul National University), Jong Lee(Ulsan College), Yon Su Kim(Seoul National University), Sunhwa Lee(Seoul National University), Yong Chul Kim(New Generation University College), Jinsuk Bae(Ulsan College), Jehun Song(Ulsan College)
Cited by 0
Related Papers
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
|Annals of Oncology|2018|217
A Machine Learning Approach Using Survival Statistics to Predict Graft Survival in Kidney Transplant Recipients: A Multicenter Cohort Study
|Scientific Reports|2017|125
Stressed<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>60</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math>layers on Au(001)
|Physical Review Letters|1993|117
The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients
|Transplantation|2022|114